| Stock | Price | 52 Week Range | Marketcap | EPS | Dividend Yield | Chart (24H) | Sector | Employees | Last Updated |
|---|---|---|---|---|---|---|---|---|---|
| $47.68 | 1.20B | 2.92 | 0.40% | Communication Services | 1,880 | 2 days ago | |||
| $3.86 | 143.60M | 1.16 | 0.00% | Technology | 891 | 2 days ago | |||
 146311 CALL | $0.0000 | 0.0000 | 0.00 | 0.00% | 0 | 6 years ago | |||
 280585 AHS | $0.0000 | 0.0000 | 0.00 | 0.00% | 0 | 6 years ago | |||
 162910 ICA | $0.0000 | 0.0000 | 0.00 | 0.00% | 0 | 6 years ago |
Are you poised to identify market champions before they become headline news? We are here to deliver the crème de la crème of investment opportunities, showcasing five stocks with exemplary operating margin growth that align perfectly with our rigorous analysis. Fasten your seatbelts because we’re diving into some compelling prospects that could make a significant impact on your portfolio.
The Allure of High Operating Margin Growth
Operating margin growth is more than just a metric; it’s a window into a company’s profitability and operational efficiency. It’s a critical indicator for safeguarding investments and ensuring sustainable growth. This metric is a hallmark of firms adept at converting sales into income, covering operational expenses seamlessly. For the astute investor, especially if you value independence and prefer navigating the market without leaning on mainstream financial advice, these stocks present notable opportunities.
Why does this matter? Our selection doesn’t only boast impressive operating margin growth. These companies have earned stellar ratings from Portfolio Grader, based on an array of fundamental and quantitative measures. We’re discussing stocks that excel in earnings momentum, cash flow, and sales growth—all vital aspects ensuring robust financial health. Moreover, these stocks have significantly outperformed the S&P 500, underlining their exceptional market performance.
The Standouts
Editor's Note: Analysis and insight for this article were originally sourced from our friends at InvestorPlace
1. IDT Corp. (NYSE: IDT)
Why It Shines:
IDT Corp., a titan in telecommunications, offers a variety of services, including pre-paid and rechargeable calling cards and wholesale carrier services. IDT stock has surged by a remarkable 87.5% since January 1, dwarfing the S&P 500’s 12.8% climb during the same period. With a trailing PE Ratio of 6.40, IDT not only stands out in earnings momentum and cash flow but also in its ability to generate profits efficiently.
Relevance:
IDT’s high rank in operating margin growth illuminates its profitability and operational efficiency, making it a go-to pick for investors seeking robust returns in the telecommunications sector.
For more information, get Portfolio Grader’s complete analysis of IDT stock.
Analyst Ratings:
| Item | Information |
|---|---|
| Consensus Rating | Neutral |
| Average Price Target | $15.22 |
| Current Price | $35.92 |
| Potential Gain | 30% (based on price target) |
| Number of Ratings | 25 |
Summary of Analyst Outlook:
Consensus Rating:
The consensus analyst rating for IDT Corporation stock is neutral, indicating analysts do not have a strong buy or sell opinion.
Average Price Target:
Analysts’ average price target for IDT is $15.22, suggesting a significant upside potential.
Potential Gain:
With the current price at $35.92, the stock has approximately 30% upside potential.
Sources:
2. MagnaChip Semiconductor (NYSE: MX)
Why It Shines:
MagnaChip Semiconductor specializes in the design and manufacture of mixed-signal and digital multimedia semiconductors. Currently boasting a trailing PE Ratio of 3.70, MagnaChip grabs top grades in earnings momentum, analyst earnings revisions, equity, and cash flow. This showcases an impeccable financial standing, making it a standout in the tech arena.
Relevance:
With high operating margin growth, MagnaChip offers fantastic growth potential, proving itself a lucrative opportunity for tech-savvy investors.
For more information, get Portfolio Grader’s complete analysis of MX stock.
Analyst Ratings:
| Stock | Consensus Rating | Average Price Target | Current Price | Potential Gain | Number of Ratings |
|---|---|---|---|---|---|
| MagnaChip | Moderate Buy | $8.00 | Not Listed | 64.27% | 4 Buy, 3 Hold, 0 Sell |
| Methanex | Moderate Buy | C$76.22 | Not Listed | 18.17% | 8 Buy, 3 Hold, 0 Sell |
Summary of Analyst Outlook:
Ratings: 4 Buy, 3 Hold, 0 Sell.
Average Price Target: $8.00.
Upside Potential: 64.27%.
Earnings Performance: Met earnings estimates 100.00% of the time in the past 12 months.
Sources:
- Zacks Investment Research
- TipRanks
- Investopedia
- TipRanks
3. magicJack (NASDAQ: CALL)
Why It Shines:
Known for its innovative VoIP services across multiple platforms, magicJack has posted strong performances in earnings momentum, earnings surprises, cash flow, and sales growth. With a trailing PE Ratio of 6.00, magicJack is an undervalued gem in the telecommunications sector, showing promising potential for appreciation.
Relevance:
magicJack‘s notable operating margin growth underscores its efficiency and profitability, making it an enticing choice for investors keen on dynamic communication technologies.
For more information, get Portfolio Grader’s complete analysis of CALL stock.
Analyst Ratings:
| Consensus Rating | Average Price Target | Current Price | Potential Gain | Number of Ratings |
|---|---|---|---|---|
| N/A | N/A | N/A | N/A | N/A |
Analysis:
The consensus rating and average price target for CALL cannot be determined due to insufficient information on analyst ratings and forecasts. This might be due to the stock not being widely covered by analysts or the information not being publicly accessible.
Sources:
4. AMN Healthcare (NYSE: AHS)
Why It Shines:
AMN Healthcare recruits healthcare professionals across the U.S. From nurses to physicians, the company’s reach is extensive. Strong in earnings growth, earnings momentum, analyst earnings revisions, and earnings surprises, AMN Healthcare proves its capability in managing profitability in a competitive sector.
Relevance:
With impressive operating margin growth, AMN Healthcare stands out for its effective management and operational efficiency, making it a prime candidate for your investment portfolio.
For more information, get Portfolio Grader’s complete analysis of AHS stock.
Analyst Ratings:
| Info | Value |
|---|---|
| Consensus Rating | Strong Buy |
| Average Price Target | $16.14 |
| Current Price | $15.30 |
| Potential Gain | 5.53% |
| Number of Ratings | 7 |
Summary of Analyst Outlook:
The analyst outlook for AHS (Admiralty Resources N.L.) is generally positive, with a consensus rating of Strong Buy and an average price target of $16.14. The stock currently trades at $15.30, suggesting a potential gain of about 5.53%.
Sources:
- TipRanks
- WSJ
5. Empresas ICA S.A.B. de C.V. (NYSE: ICA)
Why It Shines:
Specializing in engineering and construction services, Empresas ICA is a potent player in infrastructure development. With a trailing PE Ratio of 3.30, the company scores high in earnings momentum, analyst earnings revisions, and sales growth, presenting a compelling narrative for value investors.
Relevance:
Superior operating margin growth in Empresas ICA signifies cost efficiency and elevations in profitability—crucial metrics in construction and engineering. This stock is a must-watch for those eyeing infrastructure projects’ expanding market.
For more information, get Portfolio Grader’s complete analysis of ICA stock.
Analyst Ratings:
| Stock | Consensus Rating | Average Price Target | Current Price | Potential Gain | Number of Ratings |
|---|---|---|---|---|---|
| ICA Gruppen AB (0NB9) | Moderate Sell | kr489.33 | kr534.80 | -8.50% Downside | 3 |
| Orica Limited (ICA) | Strong Buy | €12.66 | €10.70 | 18.29% Upside | 10 |
Summary of Analyst Outlook:
For ICA Gruppen AB:
The average analyst price target for ICA Gruppen AB is kr489.33, representing a -8.50% downside from its current price of kr534.80. The consensus rating is Moderate Sell, indicating that a majority of analysts advise selling or holding the stock.
For Orica Limited:
The average analyst price target for Orica Limited is €12.66, representing an 18.29% upside from its current price of €10.70. The consensus rating is Strong Buy, indicating most analysts recommend buying the stock.
Sources:
In summarizing these five stellar stocks, we’ve endeavored to deliver actionable insights tailored for your high-potential investment interests. This selection, emphasizing superior operating margin growth, aligns with your quest for substantial returns and strategic autonomy—setting the stage for a prosperous investment journey.
Dive in, seize these opportunities, and let your portfolio shine!
